Based on data from preclinical studies, Omicron-tailored shots made by Moderna and Pfizer have already been approved in the United States for adults as well as for children as young as five years.
- Moderna Inc said on Monday its Omicron-tailored vaccines produced a better immune response against the BA.4/5 subvariants in a mid-to-late stage study, when given as a booster dose, compared with its original shot.
Data shows that both of Moderna's Omicron-tailored shots, mRNA-1273.214 and mRNA-1273.222, produced a higher antibody response against BA.4/5 subvariants than its original shot in vaccinated and boosted adults, the company said. Moderna, however, said levels of neutralizing antibody response dropped nearly 5-fold against the emerging subvariant BQ.1.1 when compared with BA.4/5, in an analysis of about 40 participants, although the virus neutralizing activity still remained "robust".
Rival Pfizer Inc and its German partner, BioNTech SE, said earlier this month their Omicron-tailored shot targeting the BA.4/5 subvariants produced a strong antibody response in older adults than the original shot after one month. According to government data, nearly 31.4 million Americans had received the updated shot as of Nov. 9, with around 5.1 million getting vaccinated last week.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna says bivalent COVID-19 booster shot performs better against BA.5 omicron subvariantNEW: Moderna announces that a booster dose of its bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of its original formula.
Weiterlesen »
Moderna says new booster increases protection against omicron subvariantsVaccine maker Moderna announced Monday that its new omicron-targeted booster shot reinforces a key line of immune defense by increasing levels of coronavirus-fighting antibodies that block BA.5.
Weiterlesen »
Moderna says updated booster stronger against omicron subvariantsModerna said on Monday its updated COVID-19 booster generated 'significantly higher' neutralizing antibodies against the Omicron BA.4/BA.5 subvariants than its earlier shot.
Weiterlesen »
Moderna says updated booster stronger against omicron subvariantsModerna said on Monday its updated COVID-19 booster generated 'significantly higher' neutralizing antibodies against the Omicron BA.4/BA.5 subvariants than its earlier shot.
Weiterlesen »
Florida COVID cases rising again as BQ subvariants of omicron spreadThe number of new infections grew by about 12,000 across Florida, the highest since late September.
Weiterlesen »
Moderna’s New Covid-19 Booster Produced Strong Immune Response in StudyModerna gave the first data from a company-sponsored study on its newly authorized Covid-19 booster, saying the shot produced a stronger immune response against Omicron subvariants
Weiterlesen »